Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 103 citing articles:

Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2
Abeer M. El‐Naggar, A.M.A. Hassan, Eslam B. Elkaeed, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105770-105770
Closed Access | Times Cited: 73
Interactions between gut microbiota and polyphenols: A mechanistic and metabolomic review
Hao Cheng, Dandan Zhang, Jing Wu, et al.
Phytomedicine (2023) Vol. 119, pp. 154979-154979
Closed Access | Times Cited: 58
Pimenta dioica (L.) Merr. Bioactive Constituents Exert Anti-SARS-CoV-2 and Anti-Inflammatory Activities: Molecular Docking and Dynamics, In Vitro, and In Vivo Studies
Heba A. El Gizawy, Sylvia A. Boshra, Ahmed Mostafa, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5844-5844
Open Access | Times Cited: 72
In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
Ayman Abo Elmaaty, Khaled M. Darwish, Amani Chrouda, et al.
ACS Omega (2021) Vol. 7, Iss. 1, pp. 875-899
Open Access | Times Cited: 68
Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
Ahmed A. Al‐Karmalawy, Mai M. Farid, Ahmed Mostafa, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6559-6559
Open Access | Times Cited: 67
In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus
Dalia Elebeedy, Ingy Badawy, Ayman Abo Elmaaty, et al.
Computers in Biology and Medicine (2021) Vol. 141, pp. 105149-105149
Closed Access | Times Cited: 54
Newly synthesized series of oxoindole–oxadiazole conjugates as potential anti-SARS-CoV-2 agents:in silicoandin vitrostudies
Rana M. El-Masry, Ahmed A. Al‐Karmalawy, Radwan Alnajjar, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 11, pp. 5078-5090
Closed Access | Times Cited: 54
Antispasmodic activity of carnosic acid extracted from rosmarinus officinalis: Isolation, spectroscopic characterization, DFT studies, and in silico molecular docking investigations
Kun Wei, Hitler Louis, Wilfred Emori, et al.
Journal of Molecular Structure (2022) Vol. 1260, pp. 132795-132795
Closed Access | Times Cited: 49
Synthesis, structural characterization, DFT calculations, molecular docking, and molecular dynamics simulations of a novel ferrocene derivative to unravel its potential antitumor activity
Mohamed M. Hammoud, Muhammad Khattab, Marwa Abdel‐Motaal, et al.
Journal of Biomolecular Structure and Dynamics (2022), pp. 1-18
Open Access | Times Cited: 47
Potential Valorization of Edible Nuts By-Products: Exploring the Immune-Modulatory and Antioxidants Effects of Selected Nut Shells Extracts in Relation to Their Metabolic Profiles
Mohamed A. Salem, Nora M. Aborehab, Ahmed A. Al‐Karmalawy, et al.
Antioxidants (2022) Vol. 11, Iss. 3, pp. 462-462
Open Access | Times Cited: 43
Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations
Ahmed A. Al‐Karmalawy, Mohamed S. Nafie, Moataz A. Shaldam, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 777-792
Closed Access | Times Cited: 41
A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
Nada A. Ashour, Ayman Abo Elmaaty, Amany A. Sarhan, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 685-715
Open Access | Times Cited: 40
Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
Ayman Abo Elmaaty, Wagdy M. Eldehna, Muhammad Khattab, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12235-12235
Open Access | Times Cited: 39
Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: In Vitro, in Vivo, molecular docking, molecular dynamics, and SAR studies
Mohamed M. Hammouda, Ayman Abo Elmaaty, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105995-105995
Closed Access | Times Cited: 37
Application of Rosmarinic Acid with Its Derivatives in the Treatment of Microbial Pathogens
Ourdia‐Nouara Kernou, Zahra Azzouz, Khodir Madani, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4243-4243
Open Access | Times Cited: 31
The Most Potent Natural Pharmaceuticals, Cosmetics, and Food Ingredients Isolated from Plants with Deep Eutectic Solvents
Agata Wawoczny, Danuta Gillner
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 29, pp. 10877-10900
Open Access | Times Cited: 29
A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide
Jiawei Zuo, Tao Meng, Yuanyuan Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 641-641
Open Access | Times Cited: 26
A review of typical biological activities of glycyrrhetinic acid and its derivatives
Liang Chen, Jingwen Gong, Xu Yong, et al.
RSC Advances (2024) Vol. 14, Iss. 10, pp. 6557-6597
Open Access | Times Cited: 7
Acteoside as a Multi-target Anti-SARS-CoV-2 Agent: An In-Silico Study
Francis O. Shode, Ayodeji Amobonye, Santhosh Pillai, et al.
Topics in Catalysis (2025)
Open Access
Antiviral Activity and Underlying Mechanism of Moslae Herba Aqueous Extract for Treating SARS-CoV-2
Yan Feng, Qiong Ge, Jian Gao, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 387-387
Open Access
Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
Ahmed A. Al‐Karmalawy, Raya Soltane, Ayman Abo Elmaaty, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1317-1317
Open Access | Times Cited: 39
In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library
Nasim Shahhamzehei, Sara Abdelfatah, Thomas Efferth
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 308-308
Open Access | Times Cited: 34
Ligand-based design and synthesis of N'-Benzylidene-3,4-dimethoxybenzohydrazide derivatives as potential antimicrobial agents; evaluation by in vitro, in vivo, and in silico approaches with SAR studies
Rogy R. Ezz Eldin, Marwa A. Saleh, Mohammad Hayal Alotaibi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1098-1119
Open Access | Times Cited: 34
A novel role of Nano selenium and sildenafil on streptozotocin-induced diabetic nephropathy in rats by modulation of inflammatory, oxidative, and apoptotic pathways
Mona F. El-Azab, Ahmed A. Al‐Karmalawy, Samar A. Antar, et al.
Life Sciences (2022) Vol. 303, pp. 120691-120691
Closed Access | Times Cited: 34
Ligand-based design, synthesis, computational insights, andin vitrostudies of novelN-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease
Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2112-2132
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top